Sanofi
The AI-powered COPD care coordination tool uses EHR data and natural language processing to identify and manage high-risk patients.
Sanofi invests in Zucara Therapeutics and MintNeuro raises $1.27 million in a funding round.
The alliance will expand Sanofi's trek into tech-based drug discovery and development platforms.
They will deliver connected caps for insulin and titration alerts to Japanese healthcare providers and patients.
The agreement also allows the companies to develop new or improved tools for Dario's chronic condition management platform.
This news comes just months after Exscientia went public.
The digital tool will be first marketed in Taiwan following regulatory approvals.
The joint venture will enable the companies to collaborate through a virtual platform and physical base in Paris.
Health2Sync partners with Sanofi to deliver a digital solution for diabetes patients & care provide…
Starting in Taiwan, this partnership aims to on-board clinics and hospitals nationwide over the next three years.
Panelists at BIO Digital discuss the obstacles of implementing digital tools to treat asthma and COPD patients, as well as the opportunity.